Identification of two novel variants in GNPTAB underlying mucolipidosis II in a Pakistani family
-
Muhammad Aman Khan
Abstract
Background
Mucolipidosis II is a rare inherited metabolic disorder characterized by multiple pathologies including coarse facial features, thickened skin, dysostosis multiplex, and skeletal abnormalities. The disorder results due to variants in GNPTAB leading to reduced activity of the enzyme GlcNAc-1-phosphotransferase (GlcNAc-PT).
Methods
In the present study, a consanguineous Pakistani family was diagnosed with MLII based on clinical and biochemical examination. Peripheral blood samples were collected and subjected to DNA sequencing of all coding exons along with exon-intron boundaries of GNPTAB.
Results
Molecular investigation of the family identified two novel variants c.25C > T: p.Gln9* (maternal allele) in exon 1 and c.1160C > T: p.Ala387Val (paternal allele) in exon 10 segregating in compound heterozygous form in the affected individuals.
Conclusions
The GNPTAB variant c.25C > T variant is highly plausible to undergo nonsense-mediated mRNA decay, while the GNPTAB variant c.1160C > T is located in a highly conserved domain, thus both the variants predict to lead to affect the enzyme activity. Two novel variants have been identified in GNPTAB as the underlying cause of ML-II in a Pakistani family. The study thus expands the available GNPTAB mutation spectrum.
Acknowledgments
The authors are grateful to all the individuals who participated in the study. Muhammad Aman Khan is supported by the Indigenous PhD Fellowship from the Higher Education Commission of Pakistan.
Author contributions: Muhammad Aman Khan: data curation, methodology, conceptualization. Bibi Zubaida: patient recruitment, methodology, conceptualization, writing – review and edit. Noreen Karim: conceptualization, methodology, writing – original draft, review, and edit. Huma Arshad Cheema: patient recruitment, conceptualization, clinical and diagnostic study. Muhammad Naeem: conceptualization, funding acquisition, methodology, supervision, writing – review and edit. All authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Leroy JG, Cathey S, Friez MJ. Mucolipidosis II. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReview. Seattle, WA: University of Washington, Seattle, 2012.Suche in Google Scholar
2. Leyva C, Buch M, Wierenga KJ, Berkovitz G, Seeherunvong T. A neonate with mucolipidosis II and transient secondary hyperparathyroidism. J Pediatr Endocrinol Metab 2019;32: 1399–402.10.1515/jpem-2019-0162Suche in Google Scholar
3. Kudo M, Brem MS, Canfield WM. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-Hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase α/β-subunits precursor gene. Am J Hum Genet 2006;78:451–63.10.1086/500849Suche in Google Scholar
4. Cathey SS, Leroy JG, Wood T, Eaves K, Simensen RJ, et al. Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet 2010;47:38–48.10.1136/jmg.2009.067736Suche in Google Scholar
5. Velho RV, De Pace R, Klünder S, Sperb-Ludwig F, Lourenço CM, et al. Analyses of disease-related GNPTAB mutations define a novel GlcNAc-1-phosphotransferase interaction domain and an alternative site-1 protease cleavage site. Hum Mol Genet 2015;24:3497–505.10.1093/hmg/ddv100Suche in Google Scholar
6. Bao M, Booth JL, Elmendorf BJ, Canfield WM. Bovine UDP-N-acetylglucosamine: lysosomal-enzymeN-acetylglucosamine-1-phosphotransferaseI.Purification and subunit structure. J Biol Chem 1996;271:31437–45.10.1074/jbc.271.49.31437Suche in Google Scholar
7. Tiede S, Storch S, Lubke T, Henrissat B, Bargal R, et al. Mucolipidosis II is caused by mutations in GNPTA encoding the α/β GlcNAc-1-phosphotransferase. Nat Med 2005;11:1109–12.10.1038/nm1305Suche in Google Scholar
8. Reitman ML, Kornfeld S. UDP-N-acetylglucosamine: glycoprotein N-acetylglucosamine-1-phosphotransferase. Proposed enzyme for the phosphorylation of the high mannose oligosaccharide units of lysosomal enzymes. J Biol Chem 1981;256:4275–81.10.1016/S0021-9258(19)69430-5Suche in Google Scholar
9. Singh A, Prasad R, Gupta AK, Sharma A, Alves S, et al. I Cell disease (mucolipidosis II alpha/beta): from screening to molecular diagnosis. Indian J Pediatr 2017;84:144–6.10.1007/s12098-016-2243-7Suche in Google Scholar PubMed
10. Wraith JE. Mucopolysaccharidoses and mucolipidoses. Handb Clin Neurol 2013;113:1723–29.10.1016/B978-0-444-59565-2.00042-3Suche in Google Scholar PubMed
11. Verma J, Thomas DC, Kasper DC, Sharma S, Puri RD, et al. Inherited metabolic disorders: efficacy of enzyme assays on dried blood spots for the diagnosis of lysosomal storage disorders. JIMD Rep 2016;31:15–27.10.1007/8904_2016_548Suche in Google Scholar PubMed PubMed Central
12. Group WMGRS. WHO Child Growth Standards: methods and development: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age. Geneva: World Health Organization, 2006.Suche in Google Scholar
13. Maquat LE. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1995;1:453–65.Suche in Google Scholar
14. Qian Y, van Meel E, Flanagan-Steet H, Yox A, Steet R, et al. Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc: lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition. J Biol Chem 2015;290:3045–56.10.1074/jbc.M114.612507Suche in Google Scholar PubMed PubMed Central
©2020 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Reviews
- Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review
- Does obesity have an effect on the ECG in children?
- Original Articles
- Factors associated with oxidative stress status in pediatric patients with type 1 diabetes mellitus
- The effect of concurrent resistance-aerobic training on serum cortisol level, anxiety, and quality of life in pediatric type 1 diabetes
- Psychiatric view for disorders of sex development: a 12-year experience of a multidisciplinary team in a university hospital
- Effect of high-dose vitamin D supplementation on antibody titers to heat shock protein 27 in adolescent girls
- Effects of whole-body vibration training on bone density and turnover markers in adolescent swimmers
- Estimations of total serum testosterone levels in Nigerian term neonates at birth using anogenital distance measurements
- Inborn errors of metabolism detectable by tandem mass spectrometry in Beijing
- Identification of two novel variants in GNPTAB underlying mucolipidosis II in a Pakistani family
- Predictive value of thyroxine for prognosis in pediatric septic shock: a prospective observational study
- Case Reports
- First Scandinavian case of successful pregnancy during nitisinone treatment for type 1 tyrosinemia
- A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis
- Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy
- Hyperinsulinism hyperammonaemia (HI/HA) syndrome due to GLUD1 mutation: phenotypic variations ranging from late presentation to spontaneous resolution
- Corrigendum
- Corrigendum to: The effects of a 12-week jump rope exercise program on body composition, insulin sensitivity, and academic self-efficacy in obese adolescent girls
Artikel in diesem Heft
- Frontmatter
- Reviews
- Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review
- Does obesity have an effect on the ECG in children?
- Original Articles
- Factors associated with oxidative stress status in pediatric patients with type 1 diabetes mellitus
- The effect of concurrent resistance-aerobic training on serum cortisol level, anxiety, and quality of life in pediatric type 1 diabetes
- Psychiatric view for disorders of sex development: a 12-year experience of a multidisciplinary team in a university hospital
- Effect of high-dose vitamin D supplementation on antibody titers to heat shock protein 27 in adolescent girls
- Effects of whole-body vibration training on bone density and turnover markers in adolescent swimmers
- Estimations of total serum testosterone levels in Nigerian term neonates at birth using anogenital distance measurements
- Inborn errors of metabolism detectable by tandem mass spectrometry in Beijing
- Identification of two novel variants in GNPTAB underlying mucolipidosis II in a Pakistani family
- Predictive value of thyroxine for prognosis in pediatric septic shock: a prospective observational study
- Case Reports
- First Scandinavian case of successful pregnancy during nitisinone treatment for type 1 tyrosinemia
- A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis
- Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy
- Hyperinsulinism hyperammonaemia (HI/HA) syndrome due to GLUD1 mutation: phenotypic variations ranging from late presentation to spontaneous resolution
- Corrigendum
- Corrigendum to: The effects of a 12-week jump rope exercise program on body composition, insulin sensitivity, and academic self-efficacy in obese adolescent girls
